Brainomix is an Oxford-based company specializing in the creation of AI-enabled software solutions to enable image-guided precision medicine for better treatment decisions in healthcare. Since launching as a spin-out from the University of Oxford in 2010, it has developed award-winning, AI-powered imaging biomarkers and software solutions, assisting physicians across the world to make better life-saving decisions. Its e-Stroke platform provides clinicians with the most comprehensive stroke imaging solution, driving faster treatment times and improving functional independence for patients.

To learn more about Brainomix and its technology visit www.brainomix.com